Hyperion DeFi Inc. Company Profile
NASDAQ: HYPDHealthcareBiotechnologyUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Hyperion DeFi at a glance
Hyperion DeFi Inc. (NASDAQ: HYPD) is a Biotechnology company in the Healthcare sector headquartered in Dallas, TX. Hyperion DeFi is led by Mr. Hyunsu Jung and employs about 9 people. The company's shares have traded publicly since 2018.
At a market capitalization of $51.2 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001682639, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Hyperion DeFi do?
Hyperion DeFi, Inc., a DeFi company, engages in building on Hyperliquid. It operates through two segments: Ophthalmic Technology and Digital Assets. The company focuses on the long-term strategic treasury of HYPE tokens to provide simplified exposure to the Hyperliquid blockchain ecosystem. It is also developing the Optejet User Filled Device to work with various topical ophthalmic liquids, including artificial tears and lens rewetting products. The company was formerly known as Eyenovia, Inc. and changed its name to Hyperion DeFi, Inc. in July 2025. Hyperion DeFi, Inc. was founded in 2014 and is based in Dallas, Texas.
Business description based on the company's public filings.
Company information
- Legal name
- Hyperion DeFi Inc.
- Ticker
- NASDAQ: HYPD
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Hyunsu Jung
- Employees
- 9
- Headquarters
- 3090 Nowitzki Way, Dallas, TX, United States
- Phone
- 833 393 6684
- Website
- hyperiondefi.com
- IPO year
- 2018
- Market cap
- $51.16M
- SEC CIK
- 0001682639
- Latest annual report
- 10-K · Mar 30, 2026
Companies similar to Hyperion DeFi
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| SERSerina Therapeutics Inc. | 2.01 | 0.00% | $51.05M | vs HYPD |
| INMBINmune Bio Inc. | 1.83 | -1.61% | $50.79M | vs HYPD |
| CRBUCaribou Biosciences Inc. | 0.4812 | -22.06% | $51.59M | vs HYPD |
| ANVSAnnovis Bio Inc. | 1.17 | -3.31% | $49.93M | vs HYPD |
| CRVOCervoMed Inc. | 3.28 | +3.14% | $49.59M | vs HYPD |
| EDSAEdesa Biotech Inc. | 3.66 | -5.79% | $49.45M | vs HYPD |
| BSEMBioStem Technologies Inc. | 2.64 | +10.46% | $49.29M | vs HYPD |
| EXOZeXoZymes Inc. | 5.27 | -4.87% | $49.04M | vs HYPD |